Douglas A, Green SA, Lattmer AF, et al. Are disturbances of sorbitol, phosphoinositides and Na+-K+ -ATPase regulatory involved in pathogenesis of diabetic neuropathy? Diabetes 1988; 37:688–693.

Yue DK, Broodks B. The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy. Med J Aust 1993; 159:76–79.

Masson EA, Boulton AJM. Aldose reductase inhibitors in the treatment of diabetic neuropathy: a review of the rational and clinical evidence. Drugs 1990;39:190–202.

Greene Da. Lattimer SA. Altered sorbitol and myoinositol metabolism as the basis for defective protein kinase C and Na+ -K+ -ATPase regulation in diabetic neuropathy. Ann NY Acad Sci 1986; 488:334–340.

Whiting PH, Ross IS. Increase nerve polyol levels in experimental diabetes and their reversal by sorbinil. Br Exp Pathol 1988;69:697–699.

Hotta N, Kakuta H, Fukasawa M, et al. Effects of a fructose rich diet and the aldose redutase inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin- treated rats. Diabetologia 1985;28:176–180.

Zhang JQ, Zhou YP. Inhibition of part of Chinese materia medica and their ingredients on rats’ lens aldose reductase. J Chin Mat Med 1989; 14(9):45–47.

Aida Kaoru. Kampo drugs’ on rats lens aldose reductase and human erythrocyte sorbitol accumulation. Hormone and Clinics 1985;33(1):75–76.

Mao XM, Zhang JQ, Zhou YP. Effect of silymarin and quercetin on diabetic rats’ sciatic nerve, lens and RBC sorbitol content. J Chin Endocrinol Metab 1994; 10: 44 -45.

Liu CS, Dong YH, Feng LN, et al. Observation on Chinese drugs baicalin and berberin in treating diabetic rats aldose reductase activity. J Chin Diabet Mell 1996; 4(3):163–166.

Xu BZ, Liu FP, Wang HT, et al. Effect of Atriplicis sibiricae on conduction velocity of mice tail nerve and sciatica nerve sorbitol content. CJIM 1996; 16(Sullp): 102 -104.

Xiong MQ, Tang CP, Zheng GF. Change of ultrastructure and sciatica nerve sorbital passage of diabetic rats and effect of Qitao tablet on its results. CJIM 1996; 16 (Sullp): 104–106.

Kinoshita JH. A thirty year journey in polyol pathway. Exp Eye Res 1990; 50:567–573.

Hasegawa G, Yoshinobu T, Shinichiro A. et al. Relationship between erythrocyte sorbitol content and diabetic microangiopathy in NIDDM: the study of a diet loading test. Diabetes Res Clin Practice 1991; 12(3): 143–148.

Zhang JQ, Mao XM. Zhou YP. Effect of silymarin on RBC sorbitol content and periphery nerve conduction velocity of II type diabetic patients. CJIM 1993;13(12): 725 -726.

Malone JI, Peterson MM. Red blood cell sorbitol as an indicator of polyol pathway activity inhibition by sorbinil in IDDM. Diabetes 1984;33:45–49.

Jaspan JB, Maselli R, Herold K, et al. Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor; relief of pain and improved somatic and autonomic nerve function. Lancet 1983; 2:758–762.

Judzewitsch RG, Jonathan MBBS, Jaspan B, et al. Aldose reductase inhibitor improves nerve conduction velocity in diabetic patients. N Engl J Med 1983;308:119–125.

Sima AAF, Bril V, Nathaniel V, et al. Regeneration and repair of myelinated fibers in sural nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319:548–555.

O Hare JP, Morgan MH, Alden P, et al. Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysio- logical studies of one year’s treatment with sorbinil. Diabet Med 1988;5:537–542.

Boulton AJM. The effect and safety of the aldose reductase inhibitor tolrestat in the treatment of chronic sensorimotor diabetic neuropathy. Diabetologia 1989;32:469A.

Greene DA, Bochenek W. Harati Y, et al. Biochemical and morphometic response to tolrestat in human diabetic nerve. Diabetologia 1990;33:92A.

Gonen B, Bochenek W, Beg M, et al. The effect of withdrawal of tolrestat, aldose reductase inhititor, on signs, symptoms and nerve function in diabetic neuropathy. Diabetologia 1991;34(Suppl 2): 135A.

Toda Kenji. Treating the impairment of peripheral nerve of diabetes mellitus with modern Chinese recipes. Diagnosis and Treatment 1987; 74:2330.

Ghahary A. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes 1989;38:1067–1070.